drugset / Trial / NCT03502551

ED Treatment of Suicidal Patients With Ketamine Infusion

NCT03502551 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study aims to determine if a single intravenous (IV) dose of ketamine given in the emergency department (ED) can provide a long term reduction in suicidal ideation, lower time to ED discharge, and increase discharge to home or voluntary treatment facilities all while being safe.

Timeline

Start
2019-04-01
Primary completion
2019-06-30
Completion
2019-06-30

Outcome

Outcome not reported

Stopped (Business): “Trial never received funding.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.